National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 6/14/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jeremy S. Abramson, MD

None

None

None

None

4/16/2013

Ranjana H. Advani, MD

None

Allos

None

None

9/21/2012

C. Babis Andreadis, MD, MSCE

None

Allos

None

None

5/16/2013

Nancy Bartlett, MD

None

None

None

None

6/6/2012

John C. Byrd, MD

None

None

None

None

3/26/2013

Myron S. Czuczman, MD

None

Abbott Laboratories;
Amgen Inc.;
Biogen Idec;
Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

6/12/2013

Mary Dwyer, MS

None

None

None

None

3/26/2013

Luis E. Fayad, MD

Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Wyeth Pharmaceuticals

Cell Therapeutics, Inc.;
Cephalon, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Wyeth Pharmaceuticals

None

None

6/14/2012

Andres Forero, MD

Biogen Idec;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

5/5/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Martha J. Glenn, MD

None

None

None

None

6/7/2013

Jon P. Gockerman, MD

None

None

None

None

6/11/2012

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

6/20/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Nancy Lee Harris, MD

None

None

None

None

2/8/2012

Richard T. Hoppe, MD

None

None

None

None

2/28/2013

Steven M. Horwitz, MD

Genzyme Corporation;
;
Allos;
Gloucester

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
allos;
gloucester;
Seattle Genetics

None

None

3/19/2013

Youn H. Kim, MD

None

Eisai Inc.;
Merck & Co., Inc.;
Gloucester;
Therakos, Inc.

None

None

3/10/2013

Ann S. LaCasce, MD

None

None

None

None

3/4/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Auayporn Nademanee, MD

None

Allos Company

None

None

3/15/2013

Pierluigi Porcu, MD

None

Therakos, Inc.

None

None

3/4/2013

Oliver Press, MD, PhD

None

Genentech, Inc.;
Roche Laboratories, Inc.

None

None

5/2/2013

Leonard R. Prosnitz, MD

None

None

None

None

9/29/2009

Nishitha Reddy, MD

None

None

None

None

5/10/2013

Lubomir Sokol, MD, PhD

None

Eisai Inc.;
Allos;
Gloucester

None

None

3/4/2013

Hema Sundar, PhD

None

None

None

None

2/25/2013

Lode J. Swinnen, MB, ChB

None

Abbott Laboratories;
Genentech, Inc.

None

None

6/6/2012

Julie M. Vose, MD

None

None

None

None

3/5/2013

William G. Wierda, MD, PhD

None

Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
Genzyme Corporation;
Micromet;
sanofi-aventis U.S.;
Schering-Plough Corporation

None

None

3/4/2013

Joachim Yahalom, MD

None

None

None

None

2/8/2012

Nadeem Zafar, MD

None

None

None

None

10/8/2012

Andrew D. Zelenetz, MD, PhD

None

Bristol-Myers Squibb Company;
Cephalon, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
sanofi-aventis U.S.

None

None

6/12/2013

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved